Frost & Sullivan Independent Equity Research
BiolineRx. An Opportunity to Invest in the Development of Unique Cancer Treatment Technologies
![bioline bioline](https://www.frostequityresearch.com/wp-content/uploads/elementor/thumbs/bioline-nx7oepmjwr0nqu046yc3t5fs9jyo1sg30b9j97eohk.png)
Company: BioLineRx
Sector: Pharmaceuticals
Report type: Initiation of Coverage
For all past reports click here
Published on: July 20th 2017